ACTRN12610000277044
Completed
N/A
Real time drug administration and physiological data collection during anaesthesia: observational study to evaluate the validity of current response surface models available in the literature
Department of Anaesthesiology, University of Auckland0 sites160 target enrollmentApril 7, 2010
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Validation of current response surface models (for anaesthetic drug interactions) available in the literature
- Sponsor
- Department of Anaesthesiology, University of Auckland
- Enrollment
- 160
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients receiving general anaesthesia from six demographic groups will be studied:
- •\* Healthy Adults: 18 \- 65 years; body mass index 18\.5 \- 25 (as defined by the World Health Organisation)
- •\* Cardiac bypass patients
- •\* Elderly, defined as age \> 70 years
- •\* Overweight, body mass index \> 30
- •\* Those who receive total intravenous anaesthesia
- •\* American Society of Anesthesiologists (ASA) grade 3\-4 patients undergoing emergency surgery
Exclusion Criteria
- •Patients with neurological dysfunction, head trauma, opioid dependence and renal or hepatic co\-morbidities will not be studied
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Pharmacokinetics and Therapeutic Drug Monitoring of Intravenous Sulbactam in PediatricsPK parameters of sulbactam in pediatric patients with proven or suspected multidrug resistance A. baumannii infection receiving intravenous sulbactamSulbactam, TDM, pharmacokinetics, A. baumannnii, pediatricsTCTR20221114001Ratchadapisek Sompoch Research Fund62
Active, Not Recruiting
Phase 1
Therapeutic drug monitoring and continuous infusion of antibiotics (beta-lactams) in patients with blood poisoning.BacteraemiaMedDRA version: 20.0Level: LLTClassification code 10003998Term: Bacteraemia, unspecifiedSystem Organ Class: 100000019999Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2015-002562-23-DKHvidore Hospital
Unknown
N/A
Non-invasive, Real-time Anesthetic Drug-monitoring SystemAnesthesiaNCT02776020Rambam Health Care Campus30
Not Yet Recruiting
N/A
e-Monitoring of Asthma Therapy to Improve Compliance in children.asthma, adherence, inhaled corticosteroids, real time medication monitoring (RTMM), sms-reminderNL-OMON29009Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)220
Terminated
Phase 2
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerEstrogen Receptor-positive Breast CancerGastrinomaGlucagonomaHER2-negative Breast CancerInsulinomaMucositisOral ComplicationsPancreatic Polypeptide TumorProgesterone Receptor-positive Breast CancerRecurrent Breast CancerRecurrent Islet Cell CarcinomaRecurrent Renal Cell CancerSomatostatinomaStage III Renal Cell CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerStage IV Renal Cell CancerNCT02273752Emory University2